Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 6;16(16):6828-6836.
doi: 10.1039/d5sc00322a. eCollection 2025 Apr 16.

Isothiourea-catalysed enantioselective synthesis of phosphonate-functionalised β-lactones

Affiliations

Isothiourea-catalysed enantioselective synthesis of phosphonate-functionalised β-lactones

Ffion M Platt et al. Chem Sci. .

Abstract

Despite growing interest in the reactivity and biological activity of phosphonate-containing molecules, the application of α-ketophosphonates in enantioselective formal [2 + 2] cycloadditions to generate β-lactones bearing a pendant phosphonate group remains unreported. In this manuscript, a highly diastereo- and enantioselective isothiourea-catalysed formal [2 + 2] cycloaddition of both alkyl- and aryl substituted C(1)-ammonium enolates and α-ketophosphonates is established. This strategy allows a mild, practical and scalable approach to highly enantioenriched C(3)-unsubstituted and C(3)-alkyl β-lactones bearing a phosphonate motif from their corresponding α-silyl acids, via a desilylative pathway (30 examples, up to 98%, >95 : 5 dr, >99 : 1 er). Alternatively, the use of (hetero)arylacetic acids allows the preparation of C(3)-(hetero)aryl β-lactones to be accessed in high yields and stereocontrol (19 examples, up to 98%, >95 : 5 dr, 99 : 1 er).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. (a) Importance of organophosphorus compounds; (b) previous methods of generating C(1)-ammonium enolates using isothiourea catalysts; (c) relevant background formal [4 + 2] cycloaddition with α-ketophosphonates; (d) and this work.
Fig. 2
Fig. 2. Scope and limitations of the formal [2 + 2] cycloaddition of α-silyl acids with α-ketophosphonates. All yields are isolated yields, dr determined by 1H NMR of crude reaction mixture, er determined by HPLC analysis on a chiral stationary phase, reaction scale 0.4 mmol, 25 °C maintained using an oil bath. a10 mol% HyperBTM 1 used; b1.6 equiv. of acid used, performed at 20 °C; cinitial reaction carried out on 0.4 mmol scale, scale up reaction carried out on 4.0 mmol scale, both gave 31 in 76% yield, >95 : 5 dr, >99 : 1 er; dmorpholine (5.0 equiv.) added after full conversion to β-lactone 31, 20 °C, 16 h.
Fig. 3
Fig. 3. Probing double stereodifferentiation. All yields are isolated yields, dr determined by 1H NMR of crude reaction mixture, er determined by HPLC analysis on a chiral stationary phase.
Fig. 4
Fig. 4. Epimerisation studies.
Fig. 5
Fig. 5. Scope and limitations of formal [2 + 2] cycloaddition of (hetero)arylacetic acids with α-ketophosphonates. All yields are isolated yields, dr determined by 1H NMR of crude reaction mixture, er determined by HPLC analysis on a chiral stationary phase. *α-ketophosphonate starting material showed dimerization over time (see ESI†).
Fig. 6
Fig. 6. Proposed mechanism and stereochemical rationale.

References

    1. Rodriguez J. B. Gallo-Rodriguez C. ChemMedChem. 2019;14:190–216. doi: 10.1002/cmdc.201800693. - DOI - PubMed
    1. Dill G. M., Sammons R. D., Feng P. C. C., Kohn F., Kretzmer K., Mehrsheikh A., Bleeke M., Honegger J. L., Farmer D., Wright D. and Haupfear E. A., in Glyphosate Resistance in Crops and Weeds, ed. V. K. Nandula, Wiley, 1st edn, 2010, pp. 1–33
    1. Popovics-Tóth N. Bálint E. Acta Chim. Slov. 2022;69:735–755. doi: 10.17344/acsi.2022.7648. - DOI - PubMed
    1. Lanzinger D. Salzinger S. Soller B. S. Rieger B. Ind. Eng. Chem. Res. 2015;54:1703–1712. doi: 10.1021/ie504084q. - DOI
    1. Samanta S. Zhao C.-G. J. Am. Chem. Soc. 2006;128:7442–7443. doi: 10.1021/ja062091r. - DOI - PMC - PubMed

LinkOut - more resources